HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.27B |
| Enterprise Value | 5.74B |
| P/E Ratio | 39.22 |
| PEG Ratio | -10.2 |
| Price/Sales Ratio | 0.52 |
| Price/Book Ratio | 1.8 |
| Enterprise/Revenue | 0.52 |
| Enterprise/EBITDA | 20.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 10.38B |
| Revenue/Share | 18.35 |
| Gross Profit | 854.06M |
| EBITDA | 273.15M |
| Net Income | 133.84M |
| Diluted EPS | 0.23 |
Balance Sheet
| Total Cash | 762.2M |
| Total Cash/Share | 1.31 |
| Total Debt | 741.65M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 1.71 |
| Book Value Per Share | 5.34 |
Price History
| 52-Week Change | 15.9 |
| 52-Week High | 18.13 |
| 52-Week Low | 7.54 |
| Moving Average 50 Days | 9.13 |
| Moving Average 200 Days | 10.46 |
Statistics
| Average Volume | 18.66M |
| Shares Outstanding | 579.89M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.09 |
| Last Split Factor | 3:2 |
| Last Split Date | June 14, 2011 |
AD
